Last 12 months
Inside the activity.
4 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 1 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2017 Filed Nov 2, 2017 22:39 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 11,977 | $41.72 | $499,680.44 |
DisclosureSEC source: 0001209191-17-058980 · doc4.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,588,022 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person sold these securities to fund tax withholding obligations arising from the settlement of a previously-reported security award. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 17:51 UTC |
Eichmann EricDirector · Chief Executive Officer
|
SaleOrdinary Shares | 5,598 | $41.61 | $232,917.11 |
DisclosureSEC source: 0001209191-17-058661 · doc4.xml · nonDerivative · entry 1 Eichmann Eric · CIK 0001454782 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,540 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The reporting person sold these securities to fund tax withholding obligations arising from the settlement of a previously-reported security award. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:30 UTC |
Spielman Sharon FoxDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 12,225 | $16.36 Strike: $42.19 | $200,001.00 |
DisclosureSEC source: 0001209191-17-058306 · doc4.xml · derivative · entry 1 Spielman Sharon Fox · CIK 0001669184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Underlying: Ordinary Shares · 12,225 shares Expires 2027-10-26 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:29 UTC |
de Pesquidoux HubertDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 12,225 | $16.36 Strike: $42.19 | $200,001.00 |
DisclosureSEC source: 0001209191-17-058304 · doc4.xml · derivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Underlying: Ordinary Shares · 12,225 shares Expires 2027-10-26 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:29 UTC |
WARNER JAMESDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 12,225 | $16.36 Strike: $42.19 | $200,001.00 |
DisclosureSEC source: 0001209191-17-058303 · doc4.xml · derivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Underlying: Ordinary Shares · 12,225 shares Expires 2027-10-26 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 19:54 UTC |
WARNER JAMESDirector
|
Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001209191-17-057389 · doc4.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for October 13, 2017 (1.00 = $1.1837). F4 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 19:54 UTC |
WARNER JAMESDirector
|
SaleOrdinary Shares | 1,250 | $45.97 | $57,462.50 |
DisclosureSEC source: 0001209191-17-057389 · doc4.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 17, 2017 Filed Oct 18, 2017 19:54 UTC |
WARNER JAMESDirector
|
Exercise / conversionOrdinary Shares | 1,250 | $0.83 | $1,037.50 |
DisclosureSEC source: 0001209191-17-057389 · doc4.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for October 13, 2017 (1.00 = $1.1837). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 23:56 UTC |
Fouilland BenoitChief Financial Officer
|
SaleOrdinary Shares | 6,250 | $46.02 | $287,601.88 |
DisclosureSEC source: 0001209191-17-057390 · doc4.xml · nonDerivative · entry 1 Fouilland Benoit · CIK 0001659984 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,226 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.00 to $46.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| October 02, 2017 Filed Oct 5, 2017 20:20 UTC |
Fouilland BenoitChief Financial Officer
|
Exercise / conversionEmployee Warrant (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.03 | $0.00 |
DisclosureSEC source: 0001209191-17-056133 · doc4.xml · derivative · entry 2 Fouilland Benoit · CIK 0001659984 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,221 Underlying: Ordinary Shares · 100,000 shares Expires 2022-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 5.95 euros. The U.S. dollar equivalent of the exercise price is $7.03 using the Federal Reserve Bank of New York noon buying rate for September 29, 2017 (1.00 = $1.1813). F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 02, 2017 Filed Oct 5, 2017 20:20 UTC |
Fouilland BenoitChief Financial Officer
|
Exercise / conversionOrdinary Shares | 100,000 | $7.03 | $703,000.00 |
DisclosureSEC source: 0001209191-17-056133 · doc4.xml · nonDerivative · entry 1 Fouilland Benoit · CIK 0001659984 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 5.95 euros. The U.S. dollar equivalent of the exercise price is $7.03 using the Federal Reserve Bank of New York noon buying rate for September 29, 2017 (1.00 = $1.1813). Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:02 UTC |
WARNER JAMESDirector
|
Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001576427-17-000180 · wf-form4_150585132431824.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.84 using the Federal Reserve Bank of New York noon buying rate for September 8, 2017 (1.00 = $1.2041). F5 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:02 UTC |
WARNER JAMESDirector
|
SaleOrdinary Shares | 1,250 | $42.21 | $52,762.50 |
DisclosureSEC source: 0001576427-17-000180 · wf-form4_150585132431824.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 16:02 UTC |
WARNER JAMESDirector
|
Exercise / conversionOrdinary Shares | 1,250 | $0.84 | $1,050.00 |
DisclosureSEC source: 0001576427-17-000180 · wf-form4_150585132431824.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.84 using the Federal Reserve Bank of New York noon buying rate for September 8, 2017 (1.00 = $1.2041). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 12,474 | $47.96 | $598,253.04 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 7 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,523,479 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.46 to $48.24, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 10,638 | $46.92 | $499,134.96 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 6 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535,953 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.46 to $47.45, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 15,326 | $45.84 | $702,543.84 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 5 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,546,591 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.46 to $46.41, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 23, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 2,320 | $48.86 | $113,355.20 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 4 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,561,917 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.57 to $49.31, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 23, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 26,628 | $47.93 | $1,276,280.04 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 3 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,564,237 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.54 to $48.50, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 22, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 23,445 | $49.11 | $1,151,383.95 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 2 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,590,865 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.92 to $49.55, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 22, 2017 Filed Aug 28, 2017 21:01 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 12,702 | $48.64 | $617,825.28 |
DisclosureSEC source: 0001576427-17-000178 · wf-form4_150395408679324.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614,310 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.92 to $48.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes (5)-(10) to this Form 4. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 4,875 | $48.49 | $236,388.75 |
DisclosureSEC source: 0001576427-17-000171 · wf-form4_150343230023684.xml · nonDerivative · entry 2 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,627,012 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.42 to $48.63, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 20:05 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 41,592 | $47.84 | $1,989,761.28 |
DisclosureSEC source: 0001576427-17-000171 · wf-form4_150343230023684.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,631,887 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.42 to $48.41, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (5) to this Form 4. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:06 UTC |
WARNER JAMESDirector
|
Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001576427-17-000168 · wf-form4_150291397941007.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,750 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for August 11, 2017 (1.00 = $1.1811). F5 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:06 UTC |
WARNER JAMESDirector
|
SaleOrdinary Shares | 1,250 | $51.49 | $64,362.50 |
DisclosureSEC source: 0001576427-17-000168 · wf-form4_150291397941007.xml · nonDerivative · entry 2 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:06 UTC |
WARNER JAMESDirector
|
Exercise / conversionOrdinary Shares | 1,250 | $0.83 | $1,037.50 |
DisclosureSEC source: 0001576427-17-000168 · wf-form4_150291397941007.xml · nonDerivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for August 11, 2017 (1.00 = $1.1811). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 16:05 UTC |
Eichmann EricDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $12.26 | $0.00 |
DisclosureSEC source: 0001576427-17-000165 · wf-form4_150248189599398.xml · derivative · entry 3 Eichmann Eric · CIK 0001454782 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 20,000 shares Expires 2023-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the stock option is 10.43 euros. The U.S. dollar equivalent of the exercise price is $12.26 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F5 · derivative.exercise_date: Stock option granted on April 18, 2013 under the Issuer's 2012 Stock Option Plan. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter, subject to continued service through each vesting date. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 16:05 UTC |
Eichmann EricDirector · Chief Executive Officer
|
SaleOrdinary Shares | 20,000 | $49.04 | $980,800.00 |
DisclosureSEC source: 0001576427-17-000165 · wf-form4_150248189599398.xml · nonDerivative · entry 2 Eichmann Eric · CIK 0001454782 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 16:05 UTC |
Eichmann EricDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 20,000 | $12.26 | $245,200.00 |
DisclosureSEC source: 0001576427-17-000165 · wf-form4_150248189599398.xml · nonDerivative · entry 1 Eichmann Eric · CIK 0001454782 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the stock option is 10.43 euros. The U.S. dollar equivalent of the exercise price is $12.26 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:11 UTC |
Spilman MaryChief Revenue Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $45.62 | $0.00 |
DisclosureSEC source: 0001576427-17-000162 · wf-form4_150239584659426.xml · derivative · entry 6 Spilman Mary · CIK 0001559435 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,464 Underlying: Ordinary Shares · 7,500 shares Expires 2026-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The exercise price of the stock option is 38.81 euros. The U.S. dollar equivalent of the exercise price is $45.62 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F7 · derivative.exercise_date: Stock option granted on June 28, 2016. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter, subject to continued service through each vesting date. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:11 UTC |
Spilman MaryChief Revenue Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001576427-17-000162 · wf-form4_150239584659426.xml · derivative · entry 5 Spilman Mary · CIK 0001559435 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Ordinary Shares · 12,500 shares Expires 2024-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the stock option is 24.28 euros. The U.S. dollar equivalent of the exercise price is $28.54 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F6 · derivative.exercise_date: Stock option granted on October 29, 2014. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter, subject to continued service through each vesting date. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:11 UTC |
Spilman MaryChief Revenue Officer
|
SaleOrdinary Shares | 7,500 | $49.50 | $371,250.00 |
DisclosureSEC source: 0001576427-17-000162 · wf-form4_150239584659426.xml · nonDerivative · entry 4 Spilman Mary · CIK 0001559435 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.25 to $49.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:11 UTC |
Spilman MaryChief Revenue Officer
|
Exercise / conversionOrdinary Shares | 7,500 | $45.62 | $342,150.00 |
DisclosureSEC source: 0001576427-17-000162 · wf-form4_150239584659426.xml · nonDerivative · entry 3 Spilman Mary · CIK 0001559435 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The exercise price of the stock option is 38.81 euros. The U.S. dollar equivalent of the exercise price is $45.62 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:11 UTC |
Spilman MaryChief Revenue Officer
|
SaleOrdinary Shares | 12,500 | $49.50 | $618,750.00 |
DisclosureSEC source: 0001576427-17-000162 · wf-form4_150239584659426.xml · nonDerivative · entry 2 Spilman Mary · CIK 0001559435 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.25 to $49.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:11 UTC |
Spilman MaryChief Revenue Officer
|
Exercise / conversionOrdinary Shares | 12,500 | $28.54 | $356,750.00 |
DisclosureSEC source: 0001576427-17-000162 · wf-form4_150239584659426.xml · nonDerivative · entry 1 Spilman Mary · CIK 0001559435 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the stock option is 24.28 euros. The U.S. dollar equivalent of the exercise price is $28.54 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission ("SEC"). Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:05 UTC |
Teodosiu DanChief Technology Officer
|
Exercise / conversionEmployee Warrant (right to buy) · Derivative | 1,500 | $0.00 Strike: $11.34 | $0.00 |
DisclosureSEC source: 0001576427-17-000160 · wf-form4_150239553467450.xml · derivative · entry 3 Teodosiu Dan · CIK 0001700295 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 1,500 shares Expires 2023-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $11.34 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F4 · derivative.exercise_date: Warrant granted on February 7, 2013. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:05 UTC |
Teodosiu DanChief Technology Officer
|
SaleOrdinary Shares | 1,500 | $50.10 | $75,150.00 |
DisclosureSEC source: 0001576427-17-000160 · wf-form4_150239553467450.xml · nonDerivative · entry 2 Teodosiu Dan · CIK 0001700295 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 20:05 UTC |
Teodosiu DanChief Technology Officer
|
Exercise / conversionOrdinary Shares | 1,500 | $11.34 | $17,010.00 |
DisclosureSEC source: 0001576427-17-000160 · wf-form4_150239553467450.xml · nonDerivative · entry 1 Teodosiu Dan · CIK 0001700295 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The exercise price of the warrant is 9.65 euros. The U.S. dollar equivalent of the exercise price is $11.34 using the Federal Reserve Bank of New York noon buying rate for August 4, 2017 (1.00 = $1.1754). F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 20:05 UTC |
Fouilland BenoitChief Financial Officer
|
SaleOrdinary Shares | 4,750 | $51.07 | $242,582.50 |
DisclosureSEC source: 0001576427-17-000153 · wf-form4_150170434415787.xml · nonDerivative · entry 2 Fouilland Benoit · CIK 0001659984 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F5 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.28, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 20:05 UTC |
Fouilland BenoitChief Financial Officer
|
SaleOrdinary Shares | 7,750 | $50.73 | $393,157.50 |
DisclosureSEC source: 0001576427-17-000153 · wf-form4_150170434415787.xml · nonDerivative · entry 1 Fouilland Benoit · CIK 0001659984 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,750 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.40 to $51.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (5) to this Form 4. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 27, 2017 Filed Jul 27, 2017 20:14 UTC |
Balla NathalieDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 3,915 | $0.00 Strike: $51.66 | $0.00 |
DisclosureSEC source: 0001576427-17-000147 · wf-form4_150118643089302.xml · derivative · entry 1 Balla Nathalie · CIK 0001711277 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,915 Underlying: Ordinary Shares · 3,915 shares Expires 2027-07-27 F1 · derivative.exercise_price: The exercise price of the warrant is 44.37 euros. The U.S. dollar equivalent of the exercise price is $51.66 using the European Central Bank (Close of Business) rate for July 26, 2017 (1.00 = $1.1644). F2 · derivative.exercise_date: Warrant granted on July 27, 2017. One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 27, 2017 Filed Jul 27, 2017 20:12 UTC |
Picard RachelDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 5,875 | $0.00 Strike: $51.66 | $0.00 |
DisclosureSEC source: 0001576427-17-000145 · wf-form4_150118632288794.xml · derivative · entry 1 Picard Rachel · CIK 0001711285 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,875 Underlying: Ordinary Shares · 5,875 shares Expires 2027-07-27 F1 · derivative.exercise_price: The exercise price of the warrant is 44.37 euros. The U.S. dollar equivalent of the exercise price is $51.66 using the European Central Bank (Close of Business) rate for July 26, 2017 (1.00 = $1.1644). F2 · derivative.exercise_date: Warrant granted on July 27, 2017. One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 25, 2017 Filed Jul 26, 2017 20:30 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 9,129 | $51.62 | $471,238.98 |
DisclosureSEC source: 0001576427-17-000143 · wf-form4_150110102951798.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,749,999 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.255 to $51.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 20:25 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 23,411 | $51.54 | $1,206,602.94 |
DisclosureSEC source: 0001576427-17-000141 · wf-form4_150101428854284.xml · nonDerivative · entry 4 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,759,128 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.385 to $51.99, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 20:25 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 21,334 | $50.97 | $1,087,393.98 |
DisclosureSEC source: 0001576427-17-000141 · wf-form4_150101428854284.xml · nonDerivative · entry 3 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,782,539 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.39 to $51.38, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 21, 2017 Filed Jul 25, 2017 20:25 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 30,900 | $50.26 | $1,553,034.00 |
DisclosureSEC source: 0001576427-17-000141 · wf-form4_150101428854284.xml · nonDerivative · entry 2 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,803,873 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.87 to $50.64, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 21, 2017 Filed Jul 25, 2017 20:25 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 29,058 | $49.33 | $1,433,431.14 |
DisclosureSEC source: 0001576427-17-000141 · wf-form4_150101428854284.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,834,773 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.85 to $49.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes (5)-(7) to this Form 4. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 20:06 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 11,574 | $51.27 | $593,398.98 |
DisclosureSEC source: 0001209191-17-046064 · doc4.xml · nonDerivative · entry 2 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,863,831 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.14 to $51.82, inclusive. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 20:06 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 24,594 | $50.37 | $1,238,799.78 |
DisclosureSEC source: 0001209191-17-046064 · doc4.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875,405 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.14 to $51.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (5) to this Form 4. F4 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the SEC. Read SEC document |
| July 17, 2017 Filed Jul 19, 2017 19:36 UTC |
WARNER JAMESDirector
|
Exercise / conversionNon-employee Warrant (right to buy) · Derivative | 1,250 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001209191-17-045761 · doc4.xml · derivative · entry 3 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Ordinary Shares · 1,250 shares Expires 2020-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.80 using the Federal Reserve Bank of New York noon buying rate for July 14, 2017 (1.00 = $1.1452). F4 · derivative.exercise_date: Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.